-
May 13: Cost-Effectiveness Analysis Alongside Clinical Trials - In Person at ISPOR 2025
-
May 13: Health Economic Modeling in R: A Hands-On Introduction - In Person at ISPOR 2025
-
May 13: Introduction to Applied Generative AI for HEOR - In Person at ISPOR 2025
-
May 13: A Health Economics Approach to US Value Assessment Frameworks - In Person at ISPOR 2025
-
May 13: Using LLMs to Simplify Real-World Evidence Research - In Person at ISPOR 2025
-
May 13: - Causal Inference and Causal Diagrams in Big, Real-World Observational Data and Pragmatic Trials- In Person at ISPOR 2025
-
May 13: Using RWE to Inform the Value and Affordability Assessment of Cell and Gene Therapies - In Person at ISPOR 2025
-
May 13: Valuation of Innovative Drugs - In Person at ISPOR 2025
-
May 13: Applied Cost-Effectiveness Modeling with R - In Person at ISPOR 2025
-
May 13: Valuing Health: The Generalized Risk Adjusted Cost-Effectiveness (GRACE) Model - In Person at ISPOR 2025
-
ADHD, GLP-1s, & HIV: Real-World Trends in Prescribing and Adherence
-
June 11-12: Introduction to Health Technology Assessment - Virtual
-
ISPOR HEOR Competencies: Boosting Career and Networks
-
Why Elicit Utility Weights For Cost Effectiveness Analysis Using DCEs?
-
Negative Control Outcomes in Observational Studies of Effectiveness
-
July 16-17: Practical Applications of Large Language Models for Real-World Evidence Generation and HEOR - Virtual
-
September 10-11: Communicating HEOR for Maximum Impact, Influence, and Understanding - Virtual
-
ISPOR Real-World Evidence Summit 2025
, TOKYO | JAPAN
The ISPOR Real-World Evidence Summit 2025: Through the Lens of Asia Pacific is the must-attend health economics and outcomes research (HEOR) and real-world evidence (RWE) event in Asia Pacific. The Summit brings together top experts, decision makers, and industry leaders to explore the latest breakthroughs, share cutting-edge research, and discuss innovative solutions to the region’s most pressing healthcare challenges.
-
October 13-16: Introduction to Health Economics and Outcomes Research - Virtual
-
October 29-30: Applying RWD and Novel Data Sources to Advance Patient-Centric Health Equity, Outcomes, and Economic Evaluations - Virtual